In the enduring war against diseases, a new weapon known as glycobiology is being developed and put into practice. Glycans are closely related to infectious diseases, autoimmune diseases, and the occurrence, development, and metastasis of tumors. Nucleic acids have expanded their coverage to such fields as antiviral and anticancer therapies, cardiovascular, metabolic and liver diseases, as well as various rare diseases. The successful commercialization of small nucleic acid drugs and mRNA vaccines has promoted the research and development of nucleic acid drugs, which are expected to become the third major type of drugs following small molecule and antibody drugs. 

Chair

Wang Peng

Chair professor, Southern University of Science and Technology

Invited speakers & reports

Gu Jianxin

Professor, Fudan University

Report: Functional mechanisms of hexosamine synthesis pathway regulated-immune escape in colorectal cancer

Ding Kan

Research fellow, Shanghai Institute of Materia Medica, Chinese Academy of Sciences

Report: Protective role of renal D-Glucuronyl C5-Epimerase (Glce) in the pathogenesis of kidney fibrosis 

Wang Peng

Chair professor, Southern University of Science and Technology

Report: Exploring tumor glycobiology using mRNA methods

Deng Chuxia

Chair professor, University of Macau

Report: BRCA1 insufficiency induces a hypersialylated acidic tumor microenvironment that promotes metastasis and immunotherapy resistance

Zhou Dapeng

Professor, Tongji University

Report: Structural biology and molecular dynamics of carbohydrate antigen recognition

Guan Feng

Professor, Northwest University

Report: Bisecting type sugar chains and tumors